M

Digoxin Update 2023: Are the Current Digoxin Monitoring Guidelines Harming and Potentially Killing our Seniors?

By Mary E. Money 9 Videos
0 views
July 7, 2023
Comments 26
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
61:49
Obafemi Awolowo University

Management of Heart Failure

Feat. O. A. Akinyele
27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

13:01
CCM® Therapy

EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractilit…

Feat. N. Varma
14:58
CCM® Therapy

EHRA 2024: Real-World Experience with Cardiac Contractility Modulati…

Feat. J. Kuschyk
19:53
CCM® Therapy

EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy for …

Feat. V. Reddy, N. Varma, K. Kuck, J. Kuschyk, N. Aspromonte
09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

18:34
Houston Methodist DeBakey Heart and Vascular Center

ECG Interpretation: Everything You Need to Know to Understand and In…

Feat. A. Dave
15:38
CCM® Therapy

THT 2024: CCM® Therapy - Don’t Wait!

Feat. R. Kahwash
55:57
CCM® Therapy

EHRA 2024: Cardiac Contractility Modulation: Innovation Therapy for …

Feat. K. Kuck, J. Kuschyk, V. Reddy, N. Aspromonte, N. Varma
35:16
Scripps Health

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Feat. M. Kittleson
12:30
Houston Methodist Hospital

Amyloidosis Types and Pathophysiology

Feat. B. Trachtenberg
14:49
Getinge

HFSA 2023 - Navigating MCS Selection Amidst the RCT Evidence Gap.

Feat. D. Baran
13:17
Getinge

HFSA 2023 - Physiological and Clinical Effects of Counterpulsation i…

Feat. I. Isseh
08:06
CCM® Therapy

EHRA 2024: Unmet Medical Needs in Heart Failure Management: Can Devi…

Feat. N. Aspromonte
10:38
Getinge

HFSA 2023 - Counterpulsation Applications in Heart Failure: Restrict…

Feat. R. Lee